GSK, Hansoh's targeted cancer drug hits main survival goal in China trial - Reuters
GSK, Hansoh's targeted cancer drug hits main survival goal in China trial Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMi1wFBVV95cUxNUXlQTnc4VFk4Uk1DZ194V2xNcEhDVkF4aDNmRXhtbnBaZVJ2TFpjSFRSUmF2Skh6R3FVZGNpWUVUckQxdDB3a1lOdVlPNk45REYzRzBLdk5sSnM3X3owa0EtN0k3VWVTODRkQ3JfVzFDOHNhNm5DWXF3Vm5rX0lJNVN5YVV6a1dLX3JNVFprZnZTMDJIOGlJV0hab21VLWxycDR6ZFNFV1E2cHR1REtkckVVd0szMFNMY25fN0w0YnpiV0NpdGdBbW1TSE90V0xxYko1eTZ4TQ?oc=5" target="_blank">GSK, Hansoh's targeted cancer drug hits main survival goal in China trial</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Halozyme wins court order to block Merck's injected Keytruda in select European markets - Reuters
Halozyme wins court order to block Merck's injected Keytruda in select European markets Reuters
October 7, 2026 at 05:03 PMUS FDA expands use of Novartis drug for chronic skin condition - Reuters
US FDA expands use of Novartis drug for chronic skin condition Reuters
October 7, 2026 at 04:51 PMPepsiCo running out of time to meet Elliott-inspired targets as GLP-1 threat intensifies - Reuters
PepsiCo running out of time to meet Elliott-inspired targets as GLP-1 threat intensifies Reuters
October 7, 2026 at 11:36 AMUS FDA flags four deaths in Newron's schizophrenia drug studies - Reuters
US FDA flags four deaths in Newron's schizophrenia drug studies Reuters
October 8, 2026 at 05:47 PMUS FDA approves Asahi Kasei's drug for persistent herpes infections - Reuters
US FDA approves Asahi Kasei's drug for persistent herpes infections Reuters
October 9, 2026 at 06:01 PMWHO endorses lifestyle changes over GLP-1 drugs in child obesity fight - Reuters
WHO endorses lifestyle changes over GLP-1 drugs in child obesity fight Reuters
October 7, 2026 at 07:39 AM